Skip to main content

Table 3 Prevalence of comorbidity according to demographic characteristics and screening test results. Estimates and (95% CIs)

From: An approach for prevention planning based on the prevalence and comorbidity of neurodevelopmental disorders in 6-year-old children receiving primary care consultations on the island of Menorca

Sociodemographic characteristics

Total, N (%)

Comorbidity

Presence of comorbidity

Absence of comorbidity

N (unweighted %)

Weighted % (95% CI)

N (unweighted %)

Weighted % (95% CI)

Sex

Boy

155 (53.60)

40 (70.20)

0.70 (0.56–0.81)

115 (49.60)

0.49 (0.43–0.56)

Girl

134 (46.40)

17 (29.80)

0.29 (0.18–0.43)

117 (50.40)

0.50 (0.43–0.57)

Course

Q5

120 (41.59)

20 (35.10)

0.35 (0.22–0.48)

100 (43.10)

0.44 (0.37–0.51)

Primary

162 (56.10)

37 (64.90)

0.64 (0.51–0.77)

125 (53.90)

0.55 (0.48–0.62)

Place of residence

Ciutadella

122 (42.20)

23 (4 0.40)

0.40 (0.27–0.54)

99 (42.70)

0.43 (0.36–0.49)

Alajor-Merca-Ferre

52 (18. 0)

12 (21.10)

0.21 (0.11–0.33)

40 (17.20)

0.17 (0.12–0.22)

Mao

74 (25.60)

18 (31.60)

0.31 (0.19–0.45)

56 (24.10)

0.24 (0.18–0.30)

EsCaste-St. Lluis

39 (13.30)

4 (7. 00)

0.07 (0.01–0.17)

35 (15.10)

0.15 (0.10–0.20)

Economic resources

Low

114 (39.40)

36 (63.20)

0.64 (0.50–0.76)

78 (33.60)

0.34 (0.28–0.40)

Media

27 (9.30)

4 (7. 00)

0.07 (0.02–0.17)

23 (9 0.90)

0.10 (0.06–0.14)

High

142 (49.10)

16 (28.10)

0.28 (0.17–0.42)

126 (54.30)

0.55 (0.48–0.62)

Premature birth

Yes

26 (9.0 0)

9 (15.80)

0.16 (0.07–0.29)

17 (7.30)

0.07 (0.04–0.11)

Breastfeeding

Yes

221 (76.50)

41 (71.90)

0.73 (0.59–0.84)

180 (77.60)

0.77 (0.71–0.82)

Low birth weight

Yes

34 (11.80)

8 (14. 00)

0.14 (0.06–0.26)

26 (11.20)

0.11 (0.07–0.16)

Congenital infection

Yes

6 (2.10)

3 (50.30)

0.05 (0.01–0.14)

3 (1.30)

0.01 (0.0 3–0.03)

Pregnant age > 35 years

Yes

83 (28.70)

16 (28.10)

0.28 (0.17–0.42)

67 (28.90)

0.29 (0.23–0.35)

Parental age > 45 years

Yes

11 (30.80)

3 (5.30)

0.05 (0.01–0.15)

8 (3.40)

0.03 (0.01–0.07)

Toxicity in pregnancy

Yes

35 (12.10)

7 (12.30)

0.12 (0.05–0.24)

28 (12.10)

0.12 (0.08–0.17)

Childbirth type

Eutocic

165 (57.10)

30 (52.60)

0.52 (0.39–0.66)

135 (58.20)

0.58 (0.51–0.64)

Instrumental

29 (10.0)

6 (10.50)

0.10 (0.04–0.21)

23 (9.90)

0.09 (0.06–0.14)

Cesarean section

94 (32.50)

20 (35.10)

0.35 (0.22–0.48)

74 (31.90)

0.31 (0.25–0.38)

High PROLEXIA

Yes

89 (30.80)

48 (84.20)

0.84 (0.72–0.92)

41 (17.70)

0.17 (0.13–0.23)

TDAH-Minikid

Yes

68 (23.50)

35 (61.40)

0.61 (0.47–0.74)

33 (14.20)

0.14 (0.1 0–0.19

A.Q.C.

Yes

8 (2.80)

4 (7.00)

0.07 (0.01–0.17)

4 (1.70)

0.01 (0.0 5–0.04)

TICS-Minikid

Yes

16 (50.50)

9 (15.80)

0.15 (0.07–0.27)

7 (3.00)

0.03 (0.01–0.06)

Total

 

289 (100)

57 (19.70)

0.197 (0.15–0.24)

232 (8 0.30)

0.80 (0.75–0.84)

  1. 95% CI Confidence interval: binomial success rate for a sample (Clopper-Pearson), Q5 Kindergarten, 5 years, PROLEXIA PROLEXIA Battery for the early detection and differential diagnosis of dyslexia, ADHD-MiniKid Minikid ADHD-Mini International Neuropsychiatric Interview for Children and Adolescents, AQC Autism Spectrum Quotient (Children’s version, AQ-Child), TICS-Minikid Minikid TICS-Mini International Neuropsychiatric Interview for Children and Adolescents